|
|
Drugs for Hepadnavirus Infection (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB): (show top 50)
(show all 281)
| id | | Name | Status | Phase | Clinical Trials | Cas Number | PubChem Id |
|---|
| 1 | | Thymalfasin | approved, investigational | Phase 4, Phase 3, Phase 1, Phase 2 | 27 | 62304-98-7 | | | Thymosin alpha 1 Thymosin alpha1 Valopicitabine Zadaxin |
| | 2 | | Peginterferon alfa-2a | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1 | 565 | 198153-51-4 | 5360545 | 198153-51-4 D02747 Pegasys Pegasys (TN) | Peginterferon alfa-2a Peginterferon alfa-2a (USAN/INN) Peginterferon alfa-2a (genetical recombination) Peginterferon alfa-2a (genetical recombination) (JAN) Pegylated interferon alfa-2a Pegylated interferon alpha2a |
| | 3 | | Ribavirin | approved | Phase 4, Phase 3, Phase 2 | 1003 | 36791-04-5 | 37542 | 1-.beta.-D-Ribofuranosyl-1,2,4-triazolo-3-carboxamide 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-1,2,4-triazole-3-carboxamide 1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide 1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide 1-beta-D-ribofuranosyl-1-H-1,2,4-triazole-3-carboxamide 36791-04-5 437710-49-1 66510-90-5 AA-504/07617051 AB00430481 AC1L1XXZ AC1Q1IDC AC1Q4ZGS AKOS001715163 BB_NC-0567 BPBio1_001195 BRN 0892462 BSPBio_001085 BSPBio_003352 C-Virin CHEMBL1643 CID37542 Copegus Copegus (TN) Cotronak D00423 DB00811 DRG-0028 DivK1c_000782 Drug: Ribavirin EU-0101063 FT-0082885 HMS2090L15 HMS2094O09 HMS502H04 HSDB 6513 ICN-1229 IDI1_000782 KBio1_000782 KBio2_002328 KBio2_004896 KBio2_007464 KBio3_002854 KBioGR_001804 KBioSS_002331 KS-1104 LS-1241 Lopac0_001063 MLS000028486 MLS002222317 MolPort-002-507-104 MolPort-002-885-856 NCGC00090726-01 NCGC00090726-03 NCGC00090726-04 NCGC00090726-05 NCGC00090726-06 NCGC00090726-07 NINDS_000782 NSC 163039 | NSC163039 Prestwick3_000993 R 9644 R-964 R9644_SIGMA RBV RG-964 RIBAV RTC RTCA RTP Ravanex Rebetol Rebetol (TN) Rebetron Rebretron Ribacine Ribamide Ribamidil Ribamidyl Ribasphere Ribasphere (TN) Ribav Ribavirin Ribavirin (JAN/USP/INN) Ribavirin Capsules Ribavirin Triphosphate Ribavirin [USAN:INN] Ribavirin-TP Ribavirina Ribavirina [INN-Spanish] Ribavirine Ribavirine [INN-French] Ribavirinum Ribavirinum [INN-Latin] Ribovirin Ro 20-9963/000 Ro-20-9963 S2504_Selleck SCH 18908 SMP1_000261 SMR000058315 SPECTRUM1503938 SR-01000076112-3 Spectrum3_001876 Spectrum4_001252 Spectrum5_002075 Spectrum_001826 Tribavirin UNII-49717AWG6K Varazid Vilona Viramid Viramide Virazid Virazide Virazole Virazole (Ribavirin) Inhalation Solution Virazole (TN) Virazole 5'-triphosphate ZINC01035331 ribavirin | |
| | 4 | | Neomycin | approved, vet_approved | Phase 4 | 50 | 1404-04-2 | 8378 | (1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-D-glucopyranoside (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol 11025-81-3 119-04-0 1393-86-8 1404-04-2 1405-10-3 (sulfate (salt)) 4-18-00-07476 (Beilstein Handbook Reference) 72131_FLUKA AB00443887 AC1L1QVH Actilin Actiline Antibiotic 10676 Antibiotic produced by Streptomyces decaris. Neomycin B Antibiotique BDG-(1-4)CYY-(5-1)RIB-(3-1)IDG BDG-(1-4)NEB-(5-1)RIB-(3-1)NED BPBio1_000326 BRN 0101621 BSPBio_000296 C01737 C23H46N6O13 C25H50N6O13 CCRIS 5462 CHEBI:7508 CID8378 Caswell No. 595 D-Streptamine, O-2,6-diamino-2,6-dideoxy-.beta.-L-idopyranosyl-(1.->3)-O-.beta.-D-ribofuranosyl-(1->5)]-O-[2,6-diamino-2,6-dideoxy-.alpha.-D-glucopyranosyl-(1->4)]-2-deoxy D05140 DB00452 DB00994 EINECS 204-292-2 EINECS 215-766-3 EPA Pesticide Chemical Code 006303 Endomixin Enterfram Fradiomycin Fradiomycin B Fradiomycinum Framicetina Framicetina [INN-Spanish] Framycetin Framycetin (INN) Framycetin [INN:BAN:DCF] Framycetine Framycetine [INN-French] Framycetinum Framycetinum [INN-Latin] | Framygen Fraquinol HMS2089P15 HSDB 3242 LS-96091 LS-96095 MolPort-003-938-736 Myacine Myacyne Mycifradin Myciguent N1142_SIGMA NCGC00179612-01 NEOMYCIN AND POLYMYXIN B SULFATES NEOMYCIN B NEOMYCIN SULFATE NMY Neo-Fradin Neo-Rx Neobiotic Neobrettin Neolate Neomas Neomcin Neomicina Neomicina [DCIT] Neomin Neomycin B Sulfate Neomycin B sulfate Neomycin Sulfate Neomycin Sulphate Neomycin solution Neomycine Neomycine [INN-French] Neomycinum Neomycinum [INN-Latin] Nivemycin PIMAVECORT Prestwick3_000158 ST075177 Soframycin Soframycin Ophthalmic Soframycine Tuttomycin UNII-4BOC774388 UNII-I16QD7X297 USAF CB-19 VONAMYCIN Vonamycin powder V neomycin | |
| | 5 | | Aluminum hydroxide | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 210 | 21645-51-2 | | Al(OH)3 Aluminium hydroxide Aluminium hydroxide gel, dried | Aluminium hydroxide, dried Aluminum hydroxide gel, dried Aluminum hydroxide, dried Dried aluminium hydroxide Dried aluminum hydroxide gel |
| | 6 | | Emtricitabine | approved, investigational | Phase 4, Phase 3, Phase 2 | 457 | 143491-57-0 | 60877 | (-)-(2R,5S)-5-Fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine (-)-(2R,5S)-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine (-)-.beta.-L-FTC (-)-2',3'-Dideoxy-5-fluoro-3'-thiacytidine (-)-2'-Deoxy-5-fluoro-3'-thiacytidine (-)-FTC (-)-beta-2',3'-Dideoxy-5-fluoro-3'-thiacytidine (-)-beta-2',3'-dideoxy-5-fluoro-3'-thiacytidine (-)-cis-4-amino-5-Fluoro-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one (-)-cis-4-amino-5-fluoro-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one (2R-cis)-4-Amino-5-fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone (2R-cis)-4-amino-5-Fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone .beta.-L-(-)-(2R,5S)-5-Fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine 1-(2-(Hydroxymethyl)oxathiolan-5-yl)-5-fluorocytosine 143491-54-7 143491-57-0 145213-48-5 2',3',5-FTC 2',3'-Dideoxy-5-fluoro-3'-thiacytidine 2'-Deoxy-5-fluoro-3'-oxa-4'-thiocytidine 2'-Deoxy-5-fluoro-3'-thiacytidine 2-FTC 3'-Thia-2'.3'-dideoxy-5-fluorocytidine 4-Amino-5-fluoro-1-((2R,5S)-2-hydroxymethyl-[1,3]oxathiolan-5-yl)-1H-pyrimidin-2-one 4-Amino-5-fluoro-1-[(2R,5S)-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone 4-amino-5-Fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one 4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one 4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one 5-Fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine 5-Fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine 5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)[1,3]oxathiolan-5-yl]cytosine 524W91 AC1L1U3I AC1Q4KUB BW 1592 | BW 524W91 BW-524W91 BW524W91 C122114 C12599 C8H10FN3O3S CHEBI:31536 CHEMBL885 CID60877 Coviracil Coviracil(TM) D01199 DB00879 DRG-0208 Emtricitabin Emtricitabina Emtricitabine Emtricitabine (JAN/USAN/INN) Emtricitabinum Emtriva Emtriva (TN) Emtriva(TM) FT-0080009 HMS2089I05 HSDB 7337 LS-135838 LS-173184 NCGC00164564-01 RCV Racivir SBB066061 TL8000958 UNII-G70B4ETF4S ZINC03629271 beta-L-2',3'-dideoxy-5-fluoro-3'-thiacytidine dOTFC emtricitabine |
| | 7 | | Chlorhexidine | approved, vet_approved | Phase 4 | 499 | 55-56-1 | 9552079, 2713 | 1,1 inverted exclamation marka-Hexamethylenebis[5-(4-chlorophenyl)biguanide] 1,1'-Hexamethylene bis(5-(P-chlorophenyl)biguanide) 1,1'-Hexamethylene bis(5-(p-chlorophenyl)biguanide) 1,1'-Hexamethylenebis(5-(p-chlorophenyl)biguanide) 1,1'-Hexamethylenebis[5-(4-chlorophenyl)biguanide 1,6-Bis(5-(p-chlorophenyl)biguandino)hexane 1,6-Bis(p-chlorophenyldiguanido)hexane 1,6-Di(4'-chlorophenyldiguanido)hexane 1,6-Di(N-p-chlorophenyldiguanido)hexane 24798_FLUKA 282227_ALDRICH 348031_ALDRICH 4-12-00-01201 (Beilstein Handbook Reference) 55-56-1 AB00053427 AB1003159 AVAGARD BPBio1_000272 BRN 2826432 BSPBio_000246 BSPBio_001977 C06902 C22H30Cl2N10 CAS-55-56-1 CCRIS 9230 CHEBI:3614 CHEMBL790 CID9552079 Chlorhexidin Chlorhexidin [Czech] Chlorhexidine Chlorhexidine (INN) Chlorhexidine Base Chlorhexidine [INN:BAN] Chlorhexidine gluconate Chlorhexidinum Chlorhexidinum [INN-Latin] Cloresidina Cloresidina [DCIT] Clorhexidina Clorhexidina [INN-Spanish] D07668 DB00878 Decanoylacetaldehyde Sodium Sulfide Dentisept [veterinary] Dentisept [veterinary] (TN) DivK1c_000761 EINECS 200-238-7 Fimeil HMS1568M08 HSDB 7196 Hexadol Hibiclens Hibispray Hibistat I06-0621 I14-0050 IDI1_000761 | KBio1_000761 KBio2_000717 KBio2_003285 KBio2_005853 KBio3_001197 KBioGR_000774 KBioSS_000717 LS-43917 Lisium (*Dihydrochloride*) MK-412A MLS001332387 MLS001332388 MLS002154209 Merfen-incolore Merfen-incolore (TN) MolPort-002-541-741 N',N'''''-hexane-1,6-diylbis[N-(4-chlorophenyl)(imidodicarbonimidic diamide)] N,N''''-hexane-1,6-diylbis[N'-(4-chlorophenyl)(imidodicarbonimidic diamide)] N,N'-Bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradeca- nediimidamide N,N'-Bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediimidamide N,N'-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediimidamide NCGC00016246-01 NCGC00091025-01 NCGC00091025-02 NINDS_000761 NSC526936 Nolvasan Nolvasan (*Diacetate*) Novalsan Oro-Clense Peridex Periogard Prestwick0_000143 Prestwick1_000143 Prestwick2_000143 Prestwick3_000143 Prestwick_53 QTL1_000020 Rotersept SMR000857146 SPBio_000210 SPBio_002185 STK089248 STOCK1S-18831 Savloclens Savlon babycare Sebidin A Sodium Houttuyfonamide Soretol Spectrum2_000135 Spectrum3_000339 Spectrum4_000277 Spectrum5_001322 Spectrum_000237 Sterido Sterilon Superspray Tubulicid UNII-R4KO0DY52L chlorhexidine |
| | 8 | | Simethicone | approved | Phase 4, Phase 3 | 58 | | | | 9 | | Benzocaine | approved | Phase 4, Phase 2, Phase 3 | 2016 | 1994-09-7, 94-09-7 | 2337 | (p-(Ethoxycarbonyl)phenylamine 06952_FLUKA 112909_ALDRICH 112909_SIAL 1333-08-0 23239-88-5 23239-88-5 (hydrochloride) 4 Aminobenzoic Acid Ethyl Ester 4-(Ethoxycarbonyl)aniline 4-(Ethoxycarbonyl)phenylamine 4-14-00-01129 (Beilstein Handbook Reference) 4-Aminobenzoate 4-Aminobenzoic acid 4-Aminobenzoic acid ethyl ester 4-Aminobenzoic acid, ethyl ester 4-Carbethoxyaniline 4-amino-benzoic acid ethyl ester 4-aminobenzoic acid ethyl ester 71123-91-6 94-09-7 94-09-7 (Parent) A0271 AB00051923 AC1L1DGC AC1Q341A AC1Q64JE AE-562/40377256 AI3-02081 AKOS000119763 AR-1H9065 Acetate, Benzocaine Aethoform Aethylium paraminobenzoicum Amben ethyl ester Americaine Anaesthan-syngala Anaesthesin Anaesthesinum Anaesthin Anestezin Anestezin [Russian] Anesthesin Anesthesine Anesthone BB_SC-0019 BPBio1_001017 BRD-K75466013-001-05-2 BRN 0638434 BSPBio_000923 BSPBio_001908 Baby Anbesol Bensokain Benzoak Benzocaina Benzocaina [INN-Spanish] Benzocaine Benzocaine (USP/INN) Benzocaine Acetate Benzocaine Formate Benzocaine Hydrobromide Benzocaine Hydrochloride Benzocaine Methanesulfonate Benzocaine [INN:BAN] Benzocainum Benzocainum [INN-Latin] Benzoic acid, 4-amino-, ethyl ester Benzoic acid, 4-amino-, ethyl ester, hydrochloride Benzoic acid, amino-, ethyl ester Benzoic acid, p-amino-, ethyl ester C07527 CAS-94-09-7 CHEBI:116735 CHEMBL278172 CID2337 Caswell No. 430A Chloraseptic D001566 D00552 DB01086 Dermoplast Diet Ayds DivK1c_000932 E1501_SIGMA EINECS 202-303-5 EPA Pesticide Chemical Code 097001 ETHYL-P-AMINOBENZOATE Ethoform Ethoforme Ethyl 4-aminobenzoate Ethyl 4-aminobenzoate hydrochloride Ethyl 4-aminobenzoic acid Ethyl Aminobenzoate Ethyl PABA | Ethyl aminobenzoate Ethyl aminobenzoate (JP15) Ethyl aminobenzoate (VAN) Ethyl aminobenzoic acid Ethyl p-Aminobenzoate Ethyl p-Aminophenylcarboxylate Ethyl p-aminobenzenecarboxylate Ethyl p-aminobenzoate Ethyl p-aminobenzoic acid Ethyl p-aminophenylcarboxylate Ethylester kyseliny p-aminobenzoove Ethylester kyseliny p-aminobenzoove [Czech] Ethylis aminobenzoas Formate, Benzocaine HMS1570O05 HMS1920G09 HMS2091M11 HMS502O14 HSDB 7225 Hurricaine Hydrobromide, Benzocaine Hydrochloride, Benzocaine I05-0204 IDI1_000932 Identhesin KBio1_000932 KBio2_000474 KBio2_003042 KBio2_005610 KBio3_001408 KBioGR_000658 KBioSS_000474 Keloform LS-35847 MLS001331704 MLS002153970 Methanesulfonate, Benzocaine MolPort-000-871-526 NCGC00016352-01 NCGC00094598-01 NCGC00094598-02 NINDS_000932 NSC 122792 NSC 41531 NSC41531 NSC4688 Norcain Norcaine Norcainum Oprea1_750694 Oprea1_827402 Ora-jel Orabase-B Orthesin Otocain Outgro Parathesin Parathesin (TN) Parathesine Prestwick0_000712 Prestwick1_000712 Prestwick2_000712 Prestwick3_000712 Prestwick_991 SMR000059025 SPBio_000134 SPBio_002844 SPECTRUM1500139 STK043620 Slim Mint Gum Solarcaine Solu H Spectrum2_000117 Spectrum3_000314 Spectrum4_000249 Spectrum5_000860 Spectrum_000074 Topcaine UNII-U3RSY48JW5 WLN: ZR DVO2 ZINC12358719 benzocaine ethylaminobenzoate-4 h-4-abz-oet nchembio.182-comp4 p-(Ethoxycarbonyl)aniline p-Aminobenzoate p-Aminobenzoic acid p-Aminobenzoic acid ethyl ester p-Aminobenzoic acid, ethyl ester p-Aminobenzoic ethyl ester p-Carbethoxyaniline p-Ethoxycarboxylic Aniline p-Ethoxycarboxylic aniline | |
| | 10 | | Prednisolone | approved, vet_approved | Phase 4, Phase 2 | 1193 | 50-24-8 | 5755 | (11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione .DELTA.1-Cortisol .DELTA.1-Dehydrocortisol .DELTA.1-Dehydrohydrocortisone .DELTA.1-Hydrocortisone .delta.-Cortef .delta.-Stab 1,2-Dehydrohydrocortisone 1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione 1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol 1-Dehydrocortisol 1-Dehydrohydrocortisone 3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene 46656_FLUKA 46656_RIEDEL 50-24-8 58201-11-9 8056-11-9 AC-1773 AC1L1L2E Ak-Pred Ak-Tate Alphadrol Articulose-50 BPBio1_000164 BRD-K98039984-001-03-0 BRN 1354103 BSPBio_000148 Bio-0666 Bubbli-Pred C07369 CCRIS 980 CHEBI:8378 CHEMBL131 CID5755 CO-Hydeltra CPD000718761 Co-Hydeltra Codelcortone Cordrol Cortalone Cotogesic Cotolone D00472 D011239 DB00860 Decaprednil Decortin H Delcortol Delta F Delta(1)-dehydrohydrocortisone Delta-Cortef Delta-Cortef (TN) Delta-Ef-Cortelan Delta-Stab Delta-stab Deltacortenol Deltacortril Deltacortril Enteric Deltahydrocortisone Deltasolone Deltisilone Depo-Medrol Derpo PD Derpo Pd Dexa-Cortidelt Hostacortin H Dexa-Cortidelt hostacortin H Di Adreson F Di-Adreson F Di-Adreson-F Di-adreson F DiAdresonF Dicortol Donisolone Dydeltrone EINECS 200-021-7 Eazolin D Econopred Econopred Plus Erbacort Erbasona Estilsona Fernisolone Fernisolone P Fernisolone-P Flamasone HMS1568H10 HMS2090J05 HSDB 3385 Hostacortin H Hydeltra Hydeltra-Tba Hydeltrasol Hydeltrone Hydrodeltalone Hydrodeltisone Hydroretrocortin Hydroretrocortine I-Pred Inflamase Forte Inflamase Mild K 1557 Key-Pred Klismacort LMST02030179 LS-7669 Lentosone Lite Pred M-Predrol | MLS001304083 MLS002154250 MLS002207037 Medrol Medrol Acetate Metacortandralone Methylprednisolone Acetate Meti-Derm Meticortelone Metreton MolPort-002-507-147 NCGC00179649-01 NSC 9120 NSC9120 NSC9900 Neo-Delta-Cortef Nisolone Nor-Pred T.B.A. Ocu-Pred Ocu-Pred Forte Ophtho-Tate Orapred P0152_SIGMA P0637 P6004_SIGMA PRDL PRED-G Panafcortelone Paracortol Paracotol Pediapred Poly-Pred Precortalon Precortancyl Precortilon Precortisyl Pred Forte Pred Mild Predair Predair A Predair Forte Predalone 50 Predalone T.B.A. Predate Predate Tba Predate-50 Predcor-25 Predcor-50 Predcor-Tba Predisolone Sodium Phosphate Predne-Dome Prednelan Predni-Dome Prednicen Predniliderm Predniretard Prednis Prednisolona Prednisolona [INN-Spanish] Prednisolone (JP15/USP/INN) Prednisolone (anhydrous) Prednisolone Acetate Prednisolone Sodium Phosphate Prednisolone Tebutate Prednisolone [INN:BAN:JAN] Prednisolonum Prednisolonum [INN-Latin] Predonin Predonine Prelone Prenolone Prestwick0_000274 Prestwick1_000274 Prestwick2_000274 Prestwick3_000274 Prestwick_404 Rolisone S1737_Selleck SAM002264639 SMR000718761 SPBio_002367 Scherisolon Solone Steran Sterane Sterolone Supercortisol UNII-9PHQ9Y1OLM Ulacort Ultra Pred Ultracorten H Ultracortene H Ultracortene-H Ultracortene-Hydrogen Ultracortene-hydrogen ZINC03833821 component of Ataraxoid component of K-Predne-Dome delta(1)-Cortisol delta(1)-Dehydrocortisol delta(1)-Dehydrohydrocortisone delta(1)-Hydrocortisone delta(sup 1)-Cortisol delta(sup 1)-Dehydrocortisol delta(sup 1)-Dehydrohydrocortisone delta(sup 1)-Hydrocortisone delta-dehydrocortisol delta-dehydrohydrocortisone delta-hydrocortisone prednisolone | |
| | 11 | | Methylprednisolone | approved, vet_approved | Phase 4, Phase 2 | 1193 | 83-43-2 | 6741 | (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one (6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione (6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione (6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione .DELTA.1-6.alpha.-Methylhydrocortisone 1-Dehydro-6alpha-methylhydrocortisone 1-dehydro-6alpha-Methylhydrocortisone 1-dehydro-6α-methylhydrocortisone 11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione 11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione 11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 121673-01-6 4-08-00-03498 (Beilstein Handbook Reference) 46436_FLUKA 46436_RIEDEL 570-35-4 6 Methylprednisolone 6-Methylprednisolone 6-alpha-Methylprednisolone 6.alpha.-Methylprednisolone 6923-42-8 6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione 6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione 6alpha-Methylprednisolone 6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione 83-43-2 AC1L1N7A Artisone-Wyeth Artisone-wyeth BPBio1_000174 BRD-K35240538-001-03-1 BRN 2340300 BSPBio_000158 Besonia Bio-0658 CHEBI:6888 CHEMBL650 CID6741 CPD000058330 D00407 D008775 DB00959 Depo-Medrol (acetate) Dopomedrol EINECS 201-476-4 Esametone Firmacort HMS1568H20 HMS2090B13 HSDB 3127 LMST02030178 LS-118498 Lemod M0639_SIGMA M1665 MEPRDL MLS000028541 MLS001148159 MLS002207191 Medesone Medixon Medlone 21 | Medrate Medrol Medrol (TN) Medrol Adt Pak Medrol Dosepak Medrol adt pak Medrol dosepak Medrol, Solu-Medrol, Medrone, Methylprednisolone Medrone Mesopren Metastab Methyleneprednisolone Methylprednisolon Methylprednisolone Methylprednisolone (JP15/USP/INN) Methylprednisolone [USAN:INN:BAN:JAN] Methylprednisolone, 6-alpha Methylprednisolonum Methylprednisolonum [INN-Latin] Metilbetasone Metilprednisolona Metilprednisolona [INN-Spanish] Metilprednisolone Metilprednisolone [DCIT] Metilprednisolone [Dcit] Metipred Metrisone Metrocort Metysolon Moderin MolPort-002-528-554 NCGC00022735-03 NCI60_001657 NSC-19987 NSC19987 Nirypan Noretona Predni N Tablinen Prednol- L Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI) Prestwick0_000279 Prestwick1_000279 Prestwick2_000279 Prestwick3_000279 Prestwick_622 Promacortine Reactenol S1733_Selleck SAM002589984 SMR000058330 SPBio_002377 Sieropresol Solomet Summicort Suprametil U 7532 UNII-X4W7ZR7023 Urbason Urbasone Wyacort ZINC03875560 delta(1)-6alpha-Methylhydrocortisone delta(sup 1)-6-alpha-Methylhydrocortisone methylprednisolone methylprenisolone |
| | 12 | | Ethiodized oil | approved | Phase 4, Phase 2 | 96 | 8008-53-5 | | | | 13 | | Efavirenz | approved, investigational | Phase 4 | 409 | 154598-52-4 | 64139 | (-)-6-CHLORO-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one (-)-Efavirenz (4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one (4S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one (4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one (4S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one (S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-ben (S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one (S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one (S)-6-chloro-4-(Cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one (S)-6-chloro-4-Cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[D][1,3]oxazin-2-one 154598-52-4 1ikv 1ikw 2H-3,1-Benzoxazin-2-one, 6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-, (4S)- (9 6-chloro-4-(2-Cyclopropyl-1-ethynyl)-4-trifluoromethyl-(4S)-1,4-dihydro-2H-benzo[D][1,3]oxazin-2-one 6-chloro-4-(2-cyclopropyl-1-ethynyl)-4-trifluoromethyl-(4S)-1,4-dihydro-2H-benzo[d][1,3]oxazin-2-one AC-19049 AC1L20IX BIDD:GT0383 C08088 C14H9ClF3NO2 CHEBI:119486 CHEMBL223228 CID64139 CPD000466351 D00896 DB00625 DB07709 DMP 266 DMP-266 EFV | EFZ Efavirenz Efavirenz (JAN/INN) Efavirenzum Eravirenz HMS2051J08 HMS2090N16 HSDB 7163 L 743726 L-741211 L-743,726 L-743725 L-743726 LS-173464 MLS000759465 MLS001424087 Met-SDF-1.beta. & Efavirenz Met-Stromal Cell-derived Factor-1.beta. (Human) & Efavirenz MolPort-003-983-924 NSC742403 SAM001246667 SBB066062 SMR000466351 Stocrin Strocin (TM) Sustiva Sustiva (TM) Sustiva (TN) UNII-JE6H2O27P8 ZINC02020233 efavirenz efavirenz, (S)-isomer zoxazin-2-one Éfavirenz |
| | 14 | | rituximab | approved | Phase 4, Phase 3 | 1692 | 174722-31-7 | 10201696 | AntiCD20 IDEC-102 IDEC-C2B8 | Ig gamma-1 chain C region MabThera Mabthera Rituxan rituximab |
| | 15 | | Zidovudine | approved | Phase 4, Phase 2 | 495 | 30516-87-1 | 35370 | -Azido-3&prime -deoxythymidine 1-(3-Azido-2,3-dideoxy-beta-D-ribofuranosyl)thymine 3&prime 3' Azido 2',3' Dideoxythymidine 3' Azido 3' deoxythymidine 3'-Azido-2',3'-Dideoxythymidine 3'-Azido-3'-deoxythymidine 3'-Azido-3'-deoxythymidine & Concanavalin A 3'-Azido-3'-deoxythymidine & Erythropoietin 3'-Azido-3'-deoxythymidine & Heteropolyoxotungstate PM-19 3'-Azido-3'-deoxythymidine & Interleukin-1 3'-Azido-3'-deoxythymidine & Interleukin-2 3'-Azido-3'-deoxythymidine & Interleukin-6 3'-Azido-3'-deoxythymidine & Lithium & Erythropoietin 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-1 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-6 3'-Azido-3'-deoxythymidine & Lymphoblastoid Interferon 3'-Azido-3'-deoxythymidine & Sho-Saiko-To 3'-Azido-3'-deoxythymidine (AIDS) 3'-Azido-3'deoxythymidine & Interferon .alpha. 3'-Azidothymidine 3'-Deoxy-3'-azidothymidine 3'-azido-3'-deoxythymidine, AZT 3-Azido-3-deoxythymidine 30516-87-1 399024-19-2 A2169_SIGMA AC1L1TKL AC1Q2OEK AZT AZT & CD4(178)-PE 40 AZT & Colony-stimulating factor 2 AZT & Concanavalin A (ConA) AZT & EPO AZT & GM-CSF AZT & HPA AZT & IFN.alpha. AZT & IL-1 AZT & IL-2 AZT & IL-6 AZT & Interferon-.alpha.-2 AZT & Li & EPO AZT & Li & GM-CSF AZT & Li & IL-1 AZT & Li & IL-6 AZT & Lymphoblastoid Interferon AZT & NP (from PHCA or HSA) AZT & PM-19 AZT & SST AZT & rIFN.alpha.2 AZT & rsCD4 & rIFN.alpha.A AZT & rsT4 AZT & sCD4 AZT & srCD4 AZT (Antiviral) AZT Antiviral AZT TRANSPLACENTAL CARCINOGENESIS STUDY AZT+PRO 140 AZT, Antiviral Antiviral AZT Apo-Zidovudine Azidothymidine Aztec BB_NC-1012 BPBio1_000403 BRD-K72903603-001-04-6 BSPBio_000365 BSPBio_003153 BW A509U BW-A 509U BW-A-509U BW-A509U BWA 509U BWA-509U BWA509U C07210 CCRIS 105 CHEBI:10110 CHEBI:127307 CHEMBL129 CID35370 | CPD000058351 Compound S Cpd S D00413 D015215 DB00495 DRG-0004 DS-4152 & AZT DivK1c_000524 HMS1921J20 HMS2090G11 HMS2092D06 HMS501K06 HSDB 6515 IDI1_000524 Interferon AD + 3'-azido-3'-deoxythymidine Intron A & AZT K7 [P Ti2 W10 O40] KBio1_000524 KBio2_001828 KBio2_004396 KBio2_006964 KBio3_002653 KBioGR_000703 KBioSS_001828 LS-1159 Liposomal AZT-SN-1 Liposomal AZT-SN-3 MLS000028548 MLS001055351 MLS001076358 MLS002153202 MLS002222249 Met-SDF-1.beta. & AZT Met-SDF-1.beta. & Zidovudine MolPort-002-507-286 NCGC00023945-03 NCGC00023945-04 NCGC00023945-05 NCGC00023945-08 NCGC00178237-01 NCGC00178237-02 NINDS_000524 NSC 602670 Novo-Azt PC-SOD+AZT Prestwick3_000333 Propolis+AZT Racemic Liposomal AZT Retrovir Retrovir (TN) Retrovir(TM) SAM002548971 SMR000058351 SN-1-dipalmitoylglycerophospho-AZT (in a lipid vesicle) SN-3-dipalmitoylglycerophospho-AZT (in a lipid vesicle) SPBio_000834 SPECTRUM1502109 STK801891 Spectrum2_000927 Spectrum3_001507 Spectrum4_000332 Spectrum5_001101 Spectrum_001348 UNII-4B9XT59T7S ZDV ZIDOVUDINE [AZT] ZINC03779042 ZVD Zidovudin Zidovudina Zidovudina [Spanish] Zidovudine (JAN/USP/INN) Zidovudine EP III Zidovudine [USAN:INN:BAN:JAN] Zidovudine+PRO 140 Zidovudinum Zidovudinum [Latin] antiviral azidodeoxythymidine rIFN-beta seron & AZT racemic-dipalmitoylglycerophospho-AZT (in a lipid vesicle) zidovudin zidovudine |
| | 16 | | Ritonavir | approved, investigational | Phase 4, Phase 2, Phase 3 | 883 | 155213-67-5 | 392622 | 1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate 155213-67-5 1hxw 1sh9 5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S)-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate 5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate 538, ABT A-84538 ABBOTT-84538 ABT 538 ABT 84538 ABT-538 ABT538 AC-733 AC1L94GB AKOS000280930 Abbott 84538 BIDD:GT0387 BIDD:PXR0023 Bio-0093 C07240 C37H48N6O5S2 CHEBI:45409 CHEMBL163 CID392622 CPD000466395 D00427 D019438 | DB00503 DRG-0244 FT-0082824 HMS2051B08 HSDB 7160 LS-148860 MLS000759541 MLS001424063 MolPort-000-883-877 N-[(2S,4S,5S)-4-hydroxy-1,6-diphenyl-5-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}hexan-2-yl]-N~2~-(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl)-L-valinamide NCGC00159462-02 NSC693184 Norvir Norvir (TM) Norvir (TN) Norvir Sec RIT RTV Ritonavir Ritonavir (JAN/USAN/INN) Ritonavir [USAN] Ritonavir is an inhibitor of HIV protease used to treat HIV infection and AIDS. Ritonavirum S1185_Selleck SAM001246783 SMR000466395 STK634209 ZINC03944422 ritonavir | |
| | 17 | | Peginterferon alfa-2b | approved | Phase 4, Phase 3, Phase 2 | 307 | 99210-65-8, 215647-85-1 | | 215647-85-1 D02748 PEG-Intron PegIntron | Peginterferon alfa-2b Peginterferon alfa-2b (INN) Peginterferon alfa-2b (generical recombination) Peginterferon alfa-2b (generical recombination) (JAN) Pegintron (TN) Unitron PEG |
| | 18 | | Lamivudine | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1 | 621 | 134678-17-4 | 60825 | (+/-) (Cis)-1-[2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine (+/-)-3TC (+/-)-BCH-189 (+/-)-SddC (-)-(2'R,5'S)-1-[2'-Hydroxymethyl-5'-(1,3-oxathiolanyl)]cytosine (-)-1-((2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine (-)-1-[(2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine (-)-2'-Deoxy-3'-thiacytidine (-)-BCH 189 (-)-BCH-189 (-)-SddC (-)-beta-L-2',3'-Dideoxy-3'-thiacytidine (-)NGPB-21 (2R,cis)-4-amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one .beta.-L-(-)-2',3'-dideoxy-3'-thiacytidine & Sho-Saiko-To 134678-17-4 2',3' Dideoxy 3' thiacytidine 2',3'-Dideoxy-3'-thiacytidine 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (+/-) (Cis) 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)(2R,5S) 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)(2R,5S) & Galanthus Nivalis Agglutinin (GNA) 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)(2R,5S) & Hippeastrum hybrid agglutinin( HHA) 3'-Thia-2',3'-dideoxycytidine 3TC 3TC & GNA 3TC & SST 3TC (AIDS INITIATIVE) (AIDS INITIATIVE) 3TC and NV-01 3TC, Zeffix, Heptovir, Epivir, Epivir-HBV, Lamivudine 4-Amino-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one 480434-79-5 AC-1416 AC1L1TZZ AC1Q6C34 BCH 189 BCH-189 BCH-790 BCH189 BIDD:GT0033 Bio-0652 C07065 C8H11N3O3S CCRIS 9274 CHEBI:133986 CHEMBL141 CID60825 CPD000466319 D00353 D019259 | DB00709 DRG-0126 DTHC Epivir Epivir (TN) Epivir(TM) Epivir-HBV Epzicom FT-0082667 GG-714 GR 109714X GR-109714X GR109714X HHA & 3TC HHA & Lamivudine HMS2051D21 HSDB 7155 Hepitec Heptivir Heptodin Heptovir L0217 LMV LS-2107 Lamivir Lamivudin Lamivudina Lamivudine Lamivudine & GNA Lamivudine (JAN/USP/INN) Lamivudine [USAN:BAN:INN] Lamivudine [USAN:INN:BAN] Lamivudine [Usan:Ban:Inn] Lamivudine, (2S-cis)-Isomer Lamivudinum MLS000759424 MLS001424097 MolPort-002-507-347 NCGC00159341-03 NCGC00159341-04 NSC620753 S1706_Selleck SAM001246582 SAM002589994 SMR000466319 STK801940 UNII-2T8Q726O95 ZINC00012346 Zeffix Zefix beta-L-2',3'-Dideoxy-3'-thiacytidine beta-L-3'-Thia-2',3'-dideoxycytidine lamivudine |
| | 19 | | Tenofovir | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1 | 759 | 147127-20-6 | 464205 | (R)-9-(2-Phosphonomethoxypropyl)adenine (R)-9-(2-Phosphonylmethoxypropyl)adenine (R)-9-(2-phosphonomethoxypropyl)adenine (R)-PMPA 147127-20-6 206184-49-8 AC-760 AC1LA9BO Anh. tenofovir Anhydrous tenofovir Apropovir CHEBI:45809 CHEMBL483 CID464205 D,L-Tenofovir DB00300 GNA & Tenofovir GS 1275 GS 1278 GS1278 | HHA & Tenofovir KS-5021 MolPort-003-850-411 NCGC00167535-01 PMPA PMPA-(R) Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]- & Galanthus nivalis agglutinin (GNA) Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]- & Hippeastrum hybrid agglutinin( HHA) Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]- (9CI) Phosphonic acid, [[2-(6-amino-9H-purin-9 S1401_Selleck TDF TFV Tenefovir Tenofovir Tenofovir (anh.) Tenofovir disoproxil Tenofovir disoproxil fumarate UNII-99YXE507IL Viread Viread, Tenofovir [(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid |
| | 20 | | Telbivudine | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1 | 86 | 3424-98-4 | 159269 | 1-(2-Deoxy-beta-L-erythro-pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione 1-(2-Deoxy-beta-L-erythropentafuranosyl)-5-methyl-2,4(1H,3H)-pyrimidinedione 1-(2-Deoxy-beta-L-ribofuranosyl)-5-methyluracil 1-[(2S,4R,5S)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione 2'-Deoxy-L-thymidine 3424-98-4 AC-5632 AC1L4LJI Beta-l-thymidine CHEBI:17748 CHEMBL374731 CID159269 D06675 DB01265 Epavudine I14-8810 L-DT L-Deoxythymidine L-Thymidine L-dT L-deoxythymidine L-thymidine | LDT LDT-600 LDT600 LLT LS-186402 LS-187347 LdT NB 02B NV 02B NV-02B S1651_Selleck Sebivo Telbivudin Telbivudine Telbivudine (USAN/INN) Telbivudine [USAN] Tyzeka Tyzeka (TN) Tyzeka, Sebivo, Telbivudine UNII-2OC4HKD3SF ZINC00002159 beta-L-2'-Deoxythymidine beta-L-Thymidine | |
| | 21 | | Adefovir Dipivoxil | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1 | 134 | 142340-99-6 | 60871 | (((2-(6-Amino-9H-purin-9-yl)ethoxy)methyl)phosphinylidene)bis(oxymethylene) 2,2-dimethylpropanoate ((2-(6-Amino-9H-purin-9-yl)ethoxy)methyl)phosphonic acid, diester with hydroxymethyl pivalate 142340-99-6 9-(2-((-Bis((pivaloyloxy)methoxy)phosphinyl)methoxy)ethyl)adenine 9-(2-((Bis((pivaloyloxy)methoxy)phosphinyl)methoxy)ethyl)adenine AC-1693 AC1L1U36 ADEFOVIR DIPIVOXIL ADV AKOS005145737 Adefovir Adefovir Pivoxil Adefovir dipivoxil (USAN) Adefovir pivoxil Adefovir pivoxil (JAN) Adefovirdipivoxl Adefovirum Adéfovir Ambap142340-99-6 Bis(POM)-PMEA Bis(pivaloyloxymethyl)-9-(2-phosphonylmethoxyethyl)adenine Bis(pom)PMEA Bis-POM PMEA Bis-POM PMEA, Adefovir Dipivoxil Bis-POM PMEA, Preveon, Hepsera, Adefovir Dipivoxil C20H32N5O8P CHEMBL922 | CID60871 D01655 DB00718 FT-0082875 GS 0840 GS 840 GS-0840 GS-840 Hepsera Hepsera (TM) Hepsera (TN) I06-1150 I14-3234 LS-173141 MolPort-003-986-417 NCGC00164624-01 PMEA Piv2PMEA Preveon Propanoic acid, 2,2-dimethyl-, (((2-(6-amino-9H-purin-9-yl)ethoxy)methyl)phosphinylidene)bis(oxymethylene) ester Propanoic acid,2,2-dimethyl-(((2-(6-amino-9H-purin-9-yl)ehtoxy)mehtyl)phosphinyldiene)bis(oxymehtylene)ester S1718_Selleck TL8000938 UNII-U6Q8Z01514 YouHeDing ZINC03930376 [2-(6-aminopurin-9-yl)ethoxymethyl-(2,2-dimethylpropanoyloxymethoxy)phosphoryl]oxymethyl 2,2-dimethylpropanoate adefovir depivoxil bis-POM PMEA |
| | 22 | | Entecavir | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1 | 188 | 142217-69-4 | 153941 | 142217-69-4 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one--water (1/1) 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one 209216-23-9 6-H-Purin-6-one-,2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl] 9-((1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)guanine monohydrate AB1004838 AC-1593 AC1L4BEC Anhydrous entecavir BMS-200475 Baraclude Baraclude (TN) CHEBI:473990 CHEBI:59902 CHEMBL713 CID153941 | D04008 D07896 DB00442 ETV Entecavir Entecavir (INN) Entecavir (USAN) Entecavir (anhydrous) Entecavir anhydrous Entecavir hydrate Entecavir hydrate (JAN) Entecavirum FT-0083013 MolPort-005-942-963 S2128_Selleck SBB066120 SQ-34676 TL8000933 ZINC03802690 entecavir monohydrate | |
| | 23 | | Darunavir | approved | Phase 4 | 210 | 635728-49-3, 206361-99-1 | 213039 | (3-((4-aminobenzenesulfonyl)isobutylamino)-1-benzyl-2-hydroxypropyl)carbamic acid hexahydrofuro(2,3-b)furan-3-yl ester (3R,3AS,6AR)-HEXAHYDROFURO[2,3-B]FURAN-3-YL(1S,2R)-3-[[(4-AMINOPHENYL)SULFONYL](ISOBUTYL)AMINO]-1-BENZYL-2-HYDROXYPROPYLCARBAMATE (3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(1)-isobutylsulfanilamido)propyl)carbamate (3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl(1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamate (3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate (3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate (3R,3aS,6aR)-Hexahydrofuro(2,3-b)furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N1-isobutylsulfanilamido)propyl)carbamate (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(1)-isobutylsulfanilamido)propyl)carbamate (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl [(2S,3R)-4-{[(4-aminophenyl)sulfonyl](2-methylpropyl)amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate (3R,3aS,6aR)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate (3R,3aS,6aR)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate 206361-99-1 2f80 2f81 2f8g 2hs1 2hs2 2idw 2ien 3bvb 3cyw 3d1z 3d20 618109-00-5 AC1L4U4V AIDS073035 CHEBI:367163 CHEMBL1323 | CID213039 Carbamic acid, [(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-, (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl ester D03656 DB01264 Darunavir Darunavir (USAN/INN) Darunavir [USAN] Darunavirum Darunavirum [INN-Latin] Darunavirum [INN-latin] LS-187026 LS-187772 LS-191295 MolPort-003-846-141 N-((1S,2R)-3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-benzylpropyl)((1S,2R,5R)-4,6-dioxabicyclo(3.3.0)oct-2-yloxy)carboxamide Prezista Prezista(TM) TMC 114 TMC-114 TMC114 UIC 94017 UIC-94017 UIC-96017 UNII-YO603Y8113 [(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate [(S)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-2-hydroxy-1-((R)-phenylmethyl)-propyl]-carbamic acid (3R,3aS,6aR)-(hexahydro-furo[2,3-b]furan-3-yl) ester [(S)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-2-hydroxy-1-((R)-phenylmethyl)-propyl]-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester {(1S,2R)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamic acid (3R,3aS,6aR)-(hexahydro-furo[2,3-b]furan-3-yl) ester {(1S,2R)-3-[(4-amino-benzenesulfonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester | |
| | 24 | | Maraviroc | approved, investigational | Phase 4 | 144 | 376348-65-1 | 3002977 | 376348-65-1 4,4-Difluoro-N-((1S)-3-(exo-3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo(3.2.1)oct-8-yl)-1-phenylpropyl)cyclohexanecarboxamide 4,4-difluoro-N-[(1S)-3-[(1R,5S)-3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]cyclohexane-1-carboxamide 674782-29-7 AC-558 AC1MHEFQ CHEBI:537583 CHEMBL1201187 CHEMBL256907 CID3002977 Celsentri Celsentri(TM) DB04835 Isopropyl, 4,4-difluoro-N-((1S)-3-{(1R,3s,5S)-3-(3-methyl-5-(propan-2-yl)-4H-1,2,4-triazol-4-yl)-8-azabicyclo(3.2.1)octan-8-yl}-1-phenylpropyl)cyclohexanecarboxamide | LS-182818 MVC Maraviroc Maraviroc [USAN] PRO 140 & Maraviroc PRO 140 (Anti-CCR5 monoclonal antibody) & exo-4,4-Difluoro-N-[3-[3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]oct-8-yl]-1(S)-phenylpropyl]cyclohexanecarboxamide Selzentry Selzentry(TM) UK 427857 UK-427,857 UK-427,857 maraviroc (MVC) UK-427857 UNII-MD6P741W8A exo-4,4-Difluoro-N-[3-[3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]oct-8-yl]-1(S)-phenylpropyl]cyclohexanecarboxamide maraviroc | |
| | 25 | | Tacrolimus | approved, investigational | Phase 4, Phase 2 | 1102 | 104987-11-3 | 445643, 439492 | (-)-FK 506 (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl}-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosine-1,7,20,21(4H,23H)-tetrone 104987-11-3 109581-93-3 (Hydrate) 15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(23H)-tetrone, 3S-[3R*[E(1S*,3S*,4S*)],4S*,5R*,8S*,9E,12R*,14R*,15S*,16R*,18S*,19S*,26aR*]]-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5, 19-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-15,19-epoxy-3H-pyrido[2,1-c] [1,4] oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone 8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN AC-1182 AC1L1K7H AC1L97GB AC1L9IBU AKOS005145901 Advagraf Ambap104987-11-3 Ambap5429 Anhydrous tacrolimus BCBcMAP01_000194 BRD-K35452788-001-02-1 BSPBio-001279 BSPBio_001279 Bio-0921 Bio2_000470 Bio2_000950 C01375 C44H69NO10 CCRIS 7124 CHEBI:100924 CHEBI:61049 CHEMBL1200738 CID11158639 CID11556866 CID439492 CID445643 CID5372 CID5472317 CID6426916 CID6436007 CID6473866 CID6536850 CID6610362 CID6912836 CID9832283 CID9853905 CID9918805 CID9940643 CID9963169 CPD-10016 CPD000466356 D08556 DB00864 DivK1c_001040 FK 506 FK-506 FK5 FK506 FR 900506 FR-900506 | FR900506 FT-0082660 Fk-506 Fujimycin Graceptor HMS1362O21 HMS1792O21 HMS1990O21 HMS2051C18 HMS2093M19 HMS503O21 IDI1_001040 IDI1_002225 K506 KBio1_001040 KBio2_000619 KBio2_003187 KBio2_005755 KBio3_001097 KBio3_001098 KBioGR_000619 KBioSS_000619 L 679934 L-679934 LCP-Tacro LMPK04000003 LS-64247 MLS000759471 MLS001424054 Modigraf MolPort-003-666-518 NCGC00163470-01 NCGC00163470-02 NCGC00163470-03 NCGC00163470-04 NCGC00179232-01 NChemBio.2007.16-comp1 NINDS_001040 NSC717865 Prograf Prograf (TN) Protopic Protopy S5003_Selleck SAM001246677 SMR000466356 Tacarolimus Tacrolimus (INN) Tacrolimus (Prograf?) Tacrolimus (anhydrous) Tacrolimus anhydrous Tacrolimus hydrate Tacrolimus, anhydrous Tsukubaenolide UNII-Y5L2157C4J nchembio.2007.23-comp2 tacrolimus tacrolimus hydrate | |
| | 26 | | Edetic Acid | approved, vet_approved | Phase 4, Phase 3, Phase 2 | 99 | 60-00-4, 62-33-9 | 6049 | (ethylenedinitrilo)tetraacetic acid, ion(4−) 2,2',2'',2'''-(ethane-1,2-diyldinitrilo)tetraacetate Acide ethylenediaminetetracetique Acido edetico Acidum edeticum CaEDTA Calcium Disodium Edetate (JAN) Calcium Disodium Versenate Calcium disodium versenate (TN) | EDT EDTA EDTA, ion(4-) Edetate Calcium Edetate calcium disodium (USP) Ethylenediaminetetraacetate Ethylenediaminetetraacetic acid N,N'-1,2-Ethane diylbis-(N-(carboxymethyl)glycine) acide edetique {[-(bis-carboxymethyl-amino)-ethyl]-carboxymethyl-amino}-acetic acid | |
| | 27 | | Iron | approved | Phase 4, Phase 3, Phase 2 | 1165 | 7439-89-6 | 23925 | 02583_FLUKA 12310_ALDRICH 12310_RIEDEL 129048-51-7 14067-02-8 161135-39-3 190454-13-8 195161-83-2 199281-22-6 209309_ALDRICH 209309_SIAL 255637_ALDRICH 266213_ALDRICH 266256_ALDRICH 267945_ALDRICH 267953_ALDRICH 26Fe 338141_ALDRICH 356808_ALDRICH 356824_ALDRICH 356832_ALDRICH 39344-71-3 3ZhP 413054_ALDRICH 443783-52-6 44890_ALDRICH 44890_FLUKA 675141-17-0 70884-35-4 73135-38-3 7439-89-6 8011-79-8 8053-60-9 AC1L2N38 ATW 230 ATW 432 Ancor B Ancor en 80/150 Armco iron Atomel 28 Atomel 300M200 Atomel 500M Atomel 95 Atomiron 44MR Atomiron 5M Atomiron AFP 25 Atomiron AFP 5 C00023 C3518_SIAL C3518_SIGMA CCRIS 1580 CHEBI:18248 CID23925 Carbonyl iron Copy Powder CS 105-175 D007501 DB01592 DSP 1000 DSP 128B DSP 135 DSP 135C DSP 138 Diseases (animal), iron overload Diseases, iron overload EF 1000 EF 250 EFV 200/300 EFV 250 EFV 250/400 EINECS 231-096-4 | Ed-In-Sol Eisen Electrolytic iron F 60 (metal) FE FT 3 (element) Fe Fe-40 Fe1+ Feronate Ferretts Ferro-Caps Ferro-Time Ferrousal Ferrovac E Ferrum Ferrum metallicum GS 6 HF 2 (element) HL (iron) HQ (metal) HS (iron) HS 4849 HSDB 604 Hemocyte Hierro Hoeganaes ATW 230 Hoeganaes EH IRMM524A_FLUKA IRMM524B_FLUKA IRON Iron (Fe) Iron (Fe1+) Iron ion (Fe+) Iron ion(1+) Iron monocation Iron powder Iron standard for AAS Iron(1+) Iron(1+) ion Iron(III) nitrate solution Iron, carbonyl Iron, electrolytic Iron, elemental Iron, ion (Fe1+) Iron, ion (Fe1+) (8CI,9CI) Iron, reduced LOHA LS-3196 MolPort-003-925-001 NC 100 PZh-1M3 PZh-2 PZh1M1 PZh2M PZh2M1 PZh2M2 PZh3 PZh3M PZh4M PZhO Reduced iron Remko SUY-B 2 Siderol UNII-E1UOL152H7 Vitedyn-Slo Yieronia fer ferrous iron hierro | |
| | 28 | | Ethanol | approved | Phase 4 | 2137 | 64-17-5 | 702 | (C6-C9)Alkyl alcohol 02483_FLUKA 02851_FLUKA 02853_FLUKA 02854_FLUKA 02855_FLUKA 02856_FLUKA 02856_SIAL 02857_FLUKA 02857_SIAL 02858_FLUKA 02858_SIAL 02860_FLUKA 02865_FLUKA 02865_SIAL 02870_FLUKA 02870_SIAL 02875_FLUKA 02877_FLUKA 02878_FLUKA 02882_FLUKA 02882_SIAL 02883_FLUKA 02884_FLUKA 02890_FLUKA 02890_SIAL 02891_FLUKA 02891_SIAL 1-Hydroxyethane 100C.NPA 121182-78-3 187380_ALDRICH 187380_SIAL 24102_RIEDEL 24102_SIAL 24103_RIEDEL 24103_SIAL 24105_RIEDEL 24105_SIAL 24106_RIEDEL 24106_SIAL 24194_RIEDEL 24194_SIAL 245119_ALDRICH 245119_SIAL 270741_ALDRICH 270741_SIAL 277649_ALDRICH 277649_SIAL 2858_SIGMA 29221_FLUKA 32205_RIEDEL 32205_SIAL 32221_RIEDEL 32221_SIAL 32294_RIEDEL 32294_SIAL 34870_SIAL 34963_RIEDEL 39278_FLUKA 40210_ALDRICH 40210_RIEDEL 41322_FLUKA 458600_ALDRICH 458600_SIAL 459828_ALDRICH 459828_SIAL 459836_ALDRICH 459836_SIAL 459844_SIAL 48075_SUPELCO 493511_SIAL 493538_ALDRICH 493538_SIAL 493546_ALDRICH 493546_SIAL 64-17-5 676829_SIAL 68475-56-9 71076-86-3 71329-38-9 8000-16-6 8024-45-1 AC1L19TW AC1Q31MM AHD 2000 AI3-01706 ALCOHOL 5% IN D5-W Absolute Alcohol Absolute Ethanol Absolute alcohol Absolute ethanol Absolute ethyl alcohol Aethanol Aethanol [German] Aethylalkohol Alcare Hand Degermer Alcohol Alcohol (USP) Alcohol (ethyl) Alcohol Anhydrous Alcohol [USP] Alcohol anhydrous Alcohol dehydrated Alcohol denatured Alcohol etílico Alcohol, Absolute Alcohol, Dehydrated Alcohol, Diluted Alcohol, Grain Alcohol, anhydrous Alcohol, dehydrated Alcohol, denatured Alcohol, diluted Alcohol, ethyl Alcohols Alcohols, C1-3 Alcohols, C30 Alcohols, C6-9 Alcool Ethylique Alcool Etilico Alcool ethylique Alcool etilico Alcool éthylique Algrain Alkohol Alkohol [German] Alkoholu Etylowego Alkoholu etylowego Aminoethanol Anhydrol Anhydrol PM 4085 Anhydrous alcohol Anhydrous ethanol Beta-Aminoethanol Beta-Aminoethyl Alcohol Beta-Ethanolamine Beta-Hydroxyethylamine C00469 C2H5OH C2H6O CCRIS 945 CDA 19 CDA 19-200 CHEBI:16236 CHEMBL545 CID702 Caswell No. 426 Caswell No. 430 Colamine Cologne Spirit Cologne spirit Cologne spirits | D000431 D00068 DB00898 Dehydrated Ethanol Dehydrated alcohol Dehydrated ethanol Denatured Alcohol Denatured Alcohol Cd-10 Denatured Alcohol Cd-5 Denatured Alcohol Cd-5a Denatured Alcohol Sd-1 Denatured Alcohol Sd-13a Denatured Alcohol Sd-17 Denatured Alcohol Sd-23a Denatured Alcohol Sd-28 Denatured Alcohol Sd-30 Denatured Alcohol Sd-39b Denatured Alcohol Sd-39c Denatured Alcohol Sd-3a Denatured Alcohol Sd-40m Denatured Ethanol Denatured alcohol Denatured ethanol Desinfektol EL Diluted Alcohol Distilled spirits E2385_SIGMA E7023_ALDRICH E7023_SIAL E7148_ALDRICH E7148_SIAL E7517_SIGMA EINECS 200-578-6 EINECS 270-649-4 EOH EOX ETA Envision Conditioner Pdd 9020 Esumiru WK 88 EtOH Etanolo Etanolo [Italian] Ethanol (9CI) Ethanol 200 Proof Ethanol 200 proof Ethanol Absolute Ethanol Absolute Bp Ethanol Anhydrous Ethanol Extra Pure Ethanol Vapor Ethanol [JAN] Ethanol solution Ethanol, Silent Spirit Ethanol, undenatured Ethanolum anhydricum Ethicap Ethyl Alcohol Ethyl Alcohol & Water, 10% Ethyl Alcohol & Water, 20% Ethyl Alcohol & Water, 30% Ethyl Alcohol & Water, 40% Ethyl Alcohol & Water, 5% Ethyl Alcohol & Water, 50% Ethyl Alcohol & Water, 60% Ethyl Alcohol & Water, 70% Ethyl Alcohol & Water, 80% Ethyl Alcohol & Water, 95% Ethyl Alcohol & Water, 96% Ethyl Alcohol Anhydrous Ethyl Alcohol, Anhydrous Ethyl Alcohol, Denatured Ethyl Hydrate Ethyl Hydroxide Ethyl alc Ethyl alcohol Ethyl alcohol anhydrous Ethyl alcohol in alcoholic beverages Ethyl alcohol usp Ethyl hydrate Ethyl hydroxide Ethylalcohol Ethylalcohol [Dutch] Ethylol Ethylolamine Ethyloxy Group Etylowy alkohol FEMA No. 2419 FEMA Number 2419 Fermentation alcohol Glycinol Grain alcohol HSDB 531 HSDB 82 HYDROXYETHYL GROUP Hinetoless Hydroxyethane I14-12648 IMS 99 Infinity Pure Jaysol Jaysol S LS-1539 LTBB002977 Lux Methylated Spirit Mineralised Methylated spirit Methylcarbinol MolPort-001-785-844 Molasses alcohol NCGC00091458-01 NCI-C03134 NSC 85228 NSC85228 Oxydimethylene Group Potato alcohol Punctilious ethyl alcohol Pyro QMHAIh@ Reagent Alcohol Ru-Tuss Expectorant SDA 3A SDA 40-2 SDM No. 37 SY Fresh M Sekundasprit Silent spirit Spirit Spirits of wine Spiritus vini Spirt Synasol Tecsol Tecsol C Thanol Thiofaco M-50 UNII-3K9958V90M USAF EK-1597 Undenatured Ethanol WLN: Q2 absolute alcohol alcohol alcohol etilico bmse000297 etanol ethanol ethyl alcohol grain alcohol nchem.651-comp3c nchembio.552-comp10 nchembio.94-comp20 spiritus vini Äthanol Äthylalkohol éthanol | |
| | 29 | | Etravirine | approved | Phase 4 | 74 | 269055-15-4 | 193962 | 269055-15-4 394729-17-0 4-((6-amino-5-bromo-2-((4-cyanophenyl)amino)-4-pyrimidinyl)oxy)-3,5-dimethyl-benzonitrile 4-({6-AMINO-5-BROMO-2-[(4-CYANOPHENYL)AMINO]PYRIMIDIN-4-YL}OXY)-3,5-DIMETHYLBENZONITRILE 4-[6-amino-5-bromo-2-(4-cyanoanilino)pyrimidin-4-yl]oxy-3,5-dimethylbenzonitrile 65B AC1L4XC5 CHEBI:213138 CHEMBL308954 CID193962 D04112 DAPY deriv DB07191 Diaminopyrimidine deriv Etravirine | Etravirine (JAN/USAN/INN) I06-1887 Intelence Intelence (TN) Intelence(TM) R 165335 R-165335 R165335 R165335-TMC125 ST51053273 TMC 125 TMC-125 TMC-125/R-165335 TMC125 UNII-0C50HW4FO1 ZINC00602632 | |
| | 30 | | Alprostadil | approved, investigational | Phase 4, Phase 2, Phase 1 | 71 | 745-65-3 | 149351 | (11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-enoic acid (11alpha,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-oic acid (11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid (13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate (13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid (13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate 119314-69-1 11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoic acid 7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid 745-65-3 82474_FLUKA A0593_SIAL AB00514004 AC-6095 AC1NQXHQ Alista Alprostadil Alprostadil (JP15/USP/INN) Alprostadil Alfadex Alprostadil Prostoglandin E1 Alprostadilum Alprox-TD BIDD:GT0747 BML1-F06 BPBio1_001293 BRD-K52459643-001-06-0 BSPBio_001175 BSPBio_001488 Befar Befar (TN) C04741 CHEBI:15544 CHEMBL495 CID5280723 CPD000112594 Caverject D00180 DB00770 Edex FemLife Femprox HEI-507 HMS1361K10 HMS1571K17 HMS1791K10 HMS1989K10 HMS2052L11 | HMS2090L08 IDI1_033958 LMFA03010134 MLS000758964 MLS001424250 MR 256 MR-256 MolPort-003-939-183 Muse NCGC00025234-02 NCGC00025234-03 NCGC00025234-04 NCGC00025234-05 P5515_SIAL P5515_SIGMA P7527_SIGMA P8908_SIGMA PGE-1 PGE1 PGE1 Oligomer PGE1 α-CD PGE₁ Prestwick2_001018 Prestwick3_001018 Prink Prink (TN) Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11alpha,13E,15S)-, homopolymer Prostaglandin E1 Prostaglandin e1 Prostavasin Prostin VR Prostin VR Pediatric Prostin VR pediatric (TN) Prostin vr RayVa SAM001246840 SAM001246845 SAM001247093 SMP2_000271 SMR000112594 ST50826271 Sugiran Topiglan U-10136 Viridal Vitaros alprostadil l-Prostaglandin E1 | |
| | 31 | | Lenograstim | approved | Phase 4 | 1220 | 135968-09-1 | | G-CSF (CHO cell derived) Glycosylated recombinant G-CSF Glycosylated recombinant granulocyte colony stimulating factor | Granulocyte colony stimulating factor 3 (CHO cell derived) Granulocyte colony-stimulating factor lenograstim Lenograstim (genetical recombination) Lenograstim rDNA | |
| | 32 | | Methadone | approved | Phase 4 | 330 | 76-99-3 | 4095 | (+)-Methadone (+-)-Methadone (+/-)-Methadone (+/-)-Methadone hydrochloride (+/-)-Tussal (-)-(R)-6-(Dimethylamino)-4,4-diphenyl-3-heptanone (-)-Methadone (6R)-Methadone (R)-6-(Dimethylamino)-4,4-diphenyl-3-heptanone (R)-6-(Dimethylamino)-4,4-diphenyl-3-hetpanone (S)-6-(Dimethylamino)-4,4-diphenyl-3-heptanone (±)-methadone 1095-90-5 (hydrochloride) 297-88-1 3-14-00-00278 (Beilstein Handbook Reference) 3-14-00-00279 (Beilstein Handbook Reference) 3-Hetpanone, 6-(dimethylamino)-4,4-diphenyl-, (R)- (9CI) 5653-80-5 6-(Dimethylamino)-4,4-diphenyl-3-heptanone dl-mixture 6-(dimethylamino)-4,4-diphenylheptan-3-one 6-Dimethylamino-4,4-diphenyl-3-heptanone 6-dimethylamino-4,4-di(phenyl)heptan-3-one 6S-Methadone 76-99-3 A 4624 AC-16055 AC1L1HEG AC1Q2RLW AN 148 AN-148 (*Hydrochloride*) Adanon Adanon hydrochloride Adolan Algidon Algolysin Algovetin Althose Althose hydrochloride Amidon Amidone BRN 3213667 BRN 3213668 BRN 3213669 Biscuits Butalgin C07163 CHEBI:6807 CHEMBL651 CID4095 D08195 DB00333 DEA No. 9250 DL-Methadone hydrochloride Depridol Dextromethadone Diaminon Diaminon hydrochloride DivK1c_000963 Dl-Methadone Dollies Dolly Dolofin hydrochloride Dolohepton Dolophin Dolophin hydrochloride Dolophine Dolophine (*Hydrochloride*) Dolophine HCL EINECS 200-996-9 Fenadon Fenadone | Fenadone (*Hydrochloride*) HSDB 3119 Heptadon Heptadone Heptadone (*Hydrochloride*) Heptanon Heptanon (*Hydrochloride*) Heptanon (pharmaceutical) Hoechst 10820 Hoescht 10820 (*Hydrochloride*) IDI1_000963 K 174 KBio1_000963 Ketalgin Ketalgin hydrochloride L-(+)-Methadone L-6-(Dimethylamino)-4,4-diphenyl-3-heptanone L-Polamidon L000874 LS-74485 LS-74486 LS-74487 Levometadona Levometadona [INN-Spanish] Levomethadone [INN] Levomethadonum Levomethadonum [INN-Latin] Levothyl Mecodin Mephenon Metadona Metadona [INN-Spanish] Metadona [Spanish] Metadone Metadone [DCIT] Metasedin Methadon Methadona Methadona [Spanish] Methadone (BAN) Methadone HCL Methadone HCL Intensol Methadone M Methadone [INN:BAN] Methadone hydrochloride Methadonum Methadonum [INN-Latin] Methadonum [Latin] Methadose Methaquaione Miadone Moheptan MolPort-001-785-650 NINDS_000963 Phenadone Phenadone (*Hydrochloride*) Phenadone hydrochloride Physeptone Polamidon Polamidone Polamivet Racemic methadone S-(+)-Methadone Sedo-Rapide Tussol UNII-UC6VBE7V1Z Westadone d-6-(Dimethylamino)-4,4-diphenyl-3-heptanone d-Methadone dl-Methadone l-Methadone l-Polamivet methadone |
| | 33 | | Guaifenesin | approved, vet_approved | Phase 4 | 641 | 93-14-1 | 3516 | 3-(2-Methoxyphenoxy)-1,2-propanediol 3-(O-Methoxyphenoxy)-1,2-propanediol 3-(O-Methoxyphenoxy)-propanediol-1,2 3-O-Methoxyphenoxypropane 1:2-diol Actifed C Aeronesin Amonidren Amonidrin Aresol Benylin-E Bronchol Glycerin ether Glycerin guaiacolate Glycero-guaiacol ether Glycerol a-(2-methoxyphenyl) ether Glycerol a-(O-methoxyphenyl)ether Glycerol a-guaiacyl ether Glycerol a-guiacyl ether Glycerol a-monoguaiacol ether Glycerol guaiacolate Glycerol mono(2-methoxyphenyl) ether Glycerol-a-guajakolether Glycerol-alpha-guajakolether Glyceryl guaiacol Glyceryl guaiacol ether Glyceryl guaiacolate Glyceryl guaiacolate ether Glyceryl guaiacyl ether Glyceryl guaicolate Glyceryl guiacolate | Glycerylguaiacol Guaiacol glycerol ether Guaiacol glyceryl ether Guaiacolglicerinetere Guaiacuran Guaiacurane Guaiacyl glyceryl ether Guaiamar Guaianesin Guaicol glycerine ether Guaicol glyceryl ether Guaifenesin Guaifenesine Guaiphenesin Guaiphenesine Guaiphesin Hustosil Methoxypropanediol Methphenoxydiol Metossipropandiolo O-Methoxyphenyl glyceryl ether Organidin NR Pneumomist Propanosedyl Reduton Robitussin a-Glyceryl guaiacol ether a-Glyceryl guaiacolate ether alpha-Glyceryl guaiacol ether alpha-Glyceryl guaiacolate ether guaiphenesin p-Cresyl acetate |
| | 34 | | Vitamin E | approved, nutraceutical, vet_approved | Phase 4 | 414 | 59-02-9 | 14985 | (+)-a-Tocopherol (+)-alpha-Tocopherol (+)-α-tocopherol (2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL (2R)-3,4-Dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-ol (2R,4'R,8'R)-a-Tocopherol (2R,4'R,8'R)-alpha-Tocopherol (2R,4'R,8'R)-α-tocopherol (R,R,R)-a-Tocopherol (R,R,R)-alpha-Tocopherol (R,R,R)-α-tocopherol 5,7,8-Trimethyltocol 5,7,8-trimethyltocol Amino-Opti-E Aquasol E D-alpha-Tocopherol Daltose Denamone E-200 I.U. Softgels | E-Complex-600 E-Ferol E-Vitamin succinate Eprolin Gordo-Vite E Phytogermin Phytogermine RRR-alpha-tocopherol RRR-alpha-tocopheryl Tocopherol Vitamin E Vitamin Ea Vitamin Plus E Softgells Vitec a-D-Tocopherol a-Tocopherol alpha-Tocopherol alpha-delta-Tocopherol alpha-tocopherol d-α-tocopherol delta-alpha-Tocopherol |
| | 35 | | tannic acid | approved, Nutraceutical | Phase 4, Phase 2, Phase 3 | 2016 | | | | 36 | | Ergocalciferol | approved, nutraceutical | Phase 4 | 1281 | 50-14-6 | 5280793 | 'Ergosterol irradiated' (+)-Vitamin D2 (3-beta,5Z,7E,22E)-9,10-Secoergosta-5,7,10,(19),22-tetraen-3-ol (3S,5Z,7E,14xi,17alpha,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol (3S,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol (3S,5Z,7E,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol (3beta,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol (3beta,5Z,7e,22e)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol (5E,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraen-3-ol (5Z,7E,22E)-(3S)-9,10-seco-5,7,10(19),22-ergostatetraen-3-ol (5Z,7E,22E)-(3S)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol (5Z,7e,22e)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol (5Z,7e,22e)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol 22-Tetraen 3beta 9,10,Secoergosta-5,7,10(19)-ol 31316-19-5 4-Methylene-3-[2-[tetrahydro-7a-methyl-1-(1,4,5-trimethyl-2-hexenyl)-4(3aH)-indanylidene]ethylidene]-Cyclohexanol 47768_SUPELCO 50-14-6 7489-18-1 7E677DC1-E1C4-4FC5-8F4A-BCE1857F7E87 8017-28-5 9,10,Secoergosta-5,7,10(19),22-tetraen 3.beta.-ol 9,10-Seco(5Z,7E,22E)-5,7,10(19),22-ergostatetraen-3-ol 9,10-Secoergosta-5,7,10(19),22-tetraen-3-beta-ol 9,10-Secoergosta-5,7,10(19),22-tetraen-3b-ol 95220_FLUKA 95220_SIGMA AC-1355 AC1L1FIE AC1NQXLH AC1NS4DE AC1NS9GI AC1NSSVD AC1NWAM3 AC1O5EDK AC1O6WAM ACon1_002187 Activated ergosterol BPBio1_000418 BSPBio_000380 BSPBio_001974 Buco-D C05441 C28H44O CALCIFEROL IN A GELATIN MATRIX CALCIFEROL, U.S.P. CHEBI:28934 CHEMBL1536 CID11003810 CID3249 CID5280793 CID5315257 CID5353610 CID5356615 CID5702050 CID6432478 CID6536972 Calciferol Calciferol (TN) Calciferol (vitamin D2) Calciferolum Calciferon 2 Condacaps Condocaps Condol Crtron Crystallina D-Arthin D-Tracetten D00187 DB00153 Daral Davitamon D Davitin De-rat concentrate Decaps Dee-Osterol Dee-Ron Dee-Ronal Dee-Roual Deltalin Deratol Detalup Diactol Divit urto Doral Drisdol Drisdol (TN) E5750_SIGMA EINECS 200-014-9 Ercalciol Ergocalciferol Ergocalciferol (D2) Ergocalciferol (JP15/USP) Ergocalciferol [INN:BAN:JAN] Ergocalciferol oil Ergocalciferol: Vitamin D | Ergocalciferolo Ergocalciferolo [DCIT] Ergocalciferols Ergocalciferolum Ergocalciferolum [INN-Latin] Ergorone Ergosterol activated Ergosterol irradiated Ergosterol, irradiated Ertron Fortodyl Geltabs Geltabs Vitamin D HMS1920K20 HMS2091B19 HMS502I07 HSDB 819 Haliver Hi-Deratol Hyperkil I05-0022 IDI1_000805 Infron Irradiated ergosta-5,7,22-trien-3-beta-ol Irradiated ergosta-5,7,22-trien-3.beta.-ol Irradiated ergosta-5,7,22-trien-3beta-ol Irradiated ergosterol LMST03010001 LMST03010014 LS-3228 MEGxm0_000466 MLS001332467 MLS001332468 Metadee Mina D2 MolPort-001-740-057 MolPort-001-793-930 MolPort-002-526-645 MolPort-003-666-178 MolPort-006-822-629 Mulsiferol Mykostin NCGC00142497-01 NCGC00179579-01 NCGC00179579-02 NSC 62792 NSC62792 Novovitamin-D Oleovitamin D Oleovitamin D, Synthetic Oleovitamin D2 Osteil Ostelin Prestwick3_000420 Prestwick_554 Radiostol Radstein Radsterin Rodine C Rodinec SMR000857106 SPECTRUM1500276 ST057150 STOCK1N-53397 Shock-ferol Shock-ferol sterogyl Sorex C.R Sorex C.R. Spectrum5_000666 Sterogyl Synthetic Vitamin D UNII-VS041H42XC Uvesterol D Uvesterol-D VITAMIN D2 VITAMIN D2 WATER DISPERSABLE U.S.P. VITAMIN_D2 Vigantol Vio D Vio-D Viostdrol Viosterol Viosterol in Oil Vitamin D2 Vitamin- D2 Vitamin-?D2 Vitamina D2 Vitavel-D WLN: L56 FYTJ A1 BY1&1U1Y1&Y1&1 FU2U- BL6YYTJ AU1 DQ ZINC04474571 ZINC04629876 beta-Ol bmse000510 component of Geltabs Vitamin D delta-Arthin delta-Tracetten ergocalciferol vitamin d-2 | |
| | 37 | | Cholecalciferol | approved, nutraceutical | Phase 4 | 875 | 67-97-0 | 6221, 10883523, 5280795 | ()-Vitamin D3 (+)-Vitamin D3 (+)-vitamin D3 (1S,3Z)-3-[(2e)-2-[(1R,3AR,7as)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexan-1-ol (3S,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol (3beta,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol (3beta,Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol (3β,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol (5E,7E)-9,10-Secocholesta-5,7,10-trien-3-ol (5Z,7E)-(3S)-9,10-seco-5,7,10(19)-cholestatrien-3-ol (5Z,7E)-(3S)-9,10-secocholesta-5,7,10(19)-trien-3-ol 1406-16-2 25(OH)D 3-beta,Z,7E-9,10-Secocholestr-5,7,10(19)-trien-3-ol 47763_SUPELCO 57651-82-8 67-97-0 7-Dehydrocholesterol activated 7-Dehydrocholesterol, Activated 7-Dehydrocholesterol, irradiated 7-Dehydrocholestrol, activated 8024-19-9 8050-67-7 89193_FLUKA 9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3-ol 9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3beta-ol 9,10-Secocholesta-5(Z),7(E),10(19)-trien-3(.beta.)-ol 9,10-Secocholesta-5,7,10(19)-trien-3-beta-ol 9,10-Secocholesta-5,7,10(19)-trien-3-ol 9,10-Secocholesta-5,7,10-trien-3-ol AB1002422 AC-11697 AC1L1ECK AC1L1M23 AC1LU7IZ AC1NQXLN AC1NR2UO AC1NR2UR AC1NR2UU AC1NS4AJ AC1NSHJX AC1O5EOF AC1O7GAV AC1O7GQ3 AC1O8FEU AC1O8PWJ AC1OF2GI AC1OF2GL AC1OIEW5 AC1OIEWB ACon1_001997 Activated 7-dehydrocholesterol Arachitol BPBio1_000460 BSPBio_000418 BSPBio_002408 Bio-0845 C05443 C1357_SIAL C27H44O C9756_SIGMA C9774_SIAL CAS-67-97-0 CC CCRIS 5813 CCRIS 6286 CHEBI:283119 CHEBI:28940 CHEMBL1042 CHEMBL432780 CID10000117 CID10045875 CID10340013 CID10883523 CID10894379 CID11014566 CID11025493 CID11058152 CID11463269 CID1548921 CID2735 CID5280795 CID5283710 CID5283711 CID5283712 CID5353527 CID5363362 CID6221 CID6432644 CID6604201 CID6604662 CID6708595 CID6713938 CID6992015 CID6992016 CID7067439 CID7067440 CID7251172 CID7251174 CID9821465 Calciol Cholecalciferol Cholecalciferol (D3) Cholecalciferol (JP15/USP) Cholecalciferol D3 Cholecalciferol [USAN:BAN:JAN] Cholecalciferol, D3 Cholecalciferolum Colecalciferol | Colecalciferol (INN) Colecalciferolo Colecalciferolo [DCIT] Colecalciferolum Colecalciferolum [INN-Latin] Colecalcipherol D00188 D3-Vicotrat D3-Vigantol DB00169 Delsterol Delta-D Delta-D (TN) Deparal Devaron DivK1c_006276 Duphafral D3 1000 EINECS 200-673-2 EINECS 215-797-2 EPA Pesticide Chemical Code 202901 Ebivit FeraCol Granuvit D3 HMS1569E20 HMS2092M12 HSDB 820 I05-0041 Irradiated 7-dehydrocholesterol KBio1_001220 KBio2_001643 KBio2_004211 KBio2_006779 KBio3_001628 KBioGR_001602 KBioSS_001643 LMST03020001 LMST03020219 LMST03020220 LMST03020221 LS-1570 LS-825 LT00244775 MEGxm0_000458 Micro-dee MolPort-001-740-051 MolPort-001-785-972 MolPort-003-666-021 MolPort-004-946-964 NCGC00016301-01 NCGC00017328-01 NCGC00091072-01 NCGC00142511-01 NCGC00159331-02 NCGC00159331-04 NCGC00178668-01 NCGC00179565-01 NCGC00179565-02 NEO Dohyfral D3 NSC 375571 NSC-375571 NSC375571 Oleovitamin D3 Prestwick0_000429 Prestwick1_000429 Prestwick2_000429 Prestwick3_000429 Prestwick_63 Provitamine Provitina Quintox Rampage Ricketon SMP1_000068 SPBio_001298 SPBio_002357 SR-05000001559 SR-05000001559-3 ST057172 SpecPlus_000180 Spectrum2_001369 Spectrum3_000764 Spectrum4_001201 Spectrum_001163 TNP00266 Trivitan UNII-1C6V77QF41 UPCMLD-DP152 UPCMLD-DP152:001 VITAMIN D VITAMIN D3 POWDER VITAMIN_D3 Vi-De3 Vi-de-3-hydrosol VidDe-3-hydrosol Videkhol Vigantol Vigorsan Vitamin D-3 Vitamin D3 Vitamin D3 emulsifiable Vitinc Dan-Dee-3 ZINC04474460 ZINC04492874 ZINC04492875 ZINC04492876 ZINC04492878 bmse000507 cholecalciferol colecalciferolum vitamin d-3 | |
| | 38 | | Maleic acid | experimental | Phase 4, Phase 1 | 296 | 110-16-7 | 444266 | (2Z)-2-Butenedioate (2Z)-2-Butenedioic acid (2Z)-Butene-2-dioate (2Z)-Butene-2-dioic acid (2Z)-but-2-enedioate (2Z)-but-2-enedioic acid (Z)-2-Butenedioate (Z)-2-Butenedioic acid (z)-butenedioate (z)-butenedioic acid 2-Butenedioate 2-Butenedioic acid Cis-butenedioate Cis-butenedioic acid | H2male Kyselina maleinova MAE Maleate Maleic acid Maleic acid [NA2215] Maleinic acid Malenic acid Malezid CM Scotchbond multipurpose etchant Toxilic acid cis-1,2-Ethylenedicarboxylic acid cis-2-Butenedioate cis-2-Butenedioic acid cis-But-2-enedioate cis-But-2-enedioic acid |
| | 39 | | glucocorticoids | | Phase 4, Phase 2 | 5103 | | | | 40 | | Hormones, Hormone Substitutes, and Hormone Antagonists | | Phase 4, Phase 2, Phase 1 | 13168 | | | | 41 | | Prednisolone acetate | | Phase 4, Phase 2 | 1193 | | | | 42 | | Prednisolone hemisuccinate | | Phase 4, Phase 2 | 1193 | | | | 43 | | Bone Density Conservation Agents | | Phase 4, Phase 1 | 3376 | | | | 44 | | Adefovir | | Phase 4, Phase 3, Phase 2, Phase 1 | 134 | | | | 45 | | Neuroprotective Agents | | Phase 4 | 1716 | | | | 46 | | Hormone Antagonists | | Phase 4, Phase 2, Phase 1 | 13180 | | | | 47 | | Prednisolone phosphate | | Phase 4, Phase 2 | 1193 | | | | 48 | | Methylprednisolone acetate | | Phase 4, Phase 2 | 1193 | | | | 49 | | Methylprednisolone Hemisuccinate | | Phase 4, Phase 2 | 1193 | | | | 50 | | Immunosuppressive Agents | | Phase 4, Phase 2 | 13086 | | |
Interventional clinical trials: (show top 50)
(show all 1007)
| id | Name | Status | NCT ID | Phase |
|---|
| 1 | Efficacy Optimizing Extension Study of Chronic Hepatitis B Patients With Inadequate Response to NUC Therapy | Unknown status | NCT01829685 | Phase 4 | | 2 | Antiviral Efficacy of Switching to ETV Plus TDF | Unknown status | NCT01597934 | Phase 4 | | 3 | Hepatitis B Virus (HBV) Antibody (Anti-HBs) Booster Program for the Production of Hepatitis B Immune Globulin (HBIG) | Unknown status | NCT01311674 | Phase 4 | | 4 | Improved Prevention of Perinatal Hepatitis B Transmission | Unknown status | NCT01133184 | Phase 4 | | 5 | Influence of Antiviral Treatment to the Long-Term Prognosis of Patients With Chronic HBV Infection | Unknown status | NCT00810524 | Phase 4 | | 6 | Entecavir Plus Tenofovir Combination in Subjects With Multi-drug Resistant Chronic Hepatitis B Virus Infection | Unknown status | NCT01594905 | Phase 4 | | 7 | Entecavir for Chronic Hepatitis B Patients With Persistently Normal ALT | Unknown status | NCT01833611 | Phase 4 | | 8 | Tenofovir in Late Pregnancy to Prevent Vertical Transmission of Hepatitis B Virus | Unknown status | NCT01488526 | Phase 4 | | 9 | EFFORT Extension Study | Unknown status | NCT01529255 | Phase 4 | | 10 | Safety, Long Term Immunogenicity and Lot Consistency Study of Liquid Pentavalent Combination Vaccine | Unknown status | NCT00877357 | Phase 4 | | 11 | Emtricitabine for Prevention of Vertical Transmission of HBV in Chinese Pregnant HBsAg Positive Patients | Unknown status | NCT02327715 | Phase 4 | | 12 | A Trial Comparing Entacavir and Tenofovir in Patients With HBV Decompensated Cirrhosis | Unknown status | NCT02238860 | Phase 4 | | 13 | Prophylaxis of CHB Patients With Malignant Tumor Receiving Chemotherapy | Unknown status | NCT02081469 | Phase 4 | | 14 | Entecavir for Patients With Decompensated Hepatitis B Virus (HBV)-Related Cirrhosis | Unknown status | NCT00663182 | Phase 4 | | 15 | Efficacy and Safety Study of Telbivudine to Prevent Perinatal Transmission | Unknown status | NCT00939068 | Phase 4 | | 16 | 3E Extension Study | Unknown status | NCT01834508 | Phase 4 | | 17 | Combination Hepatitis A and B Vaccine to Induce Immunity in Non-responders | Unknown status | NCT01126853 | Phase 4 | | 18 | Cellular Immunity in Adult Hepatitis B-vaccinated Serologic Non-responders | Unknown status | NCT01451801 | Phase 4 | | 19 | Pegasys Plus Entecavir Versus Entecavir Alone for Hepatitis Be Antigen-Positive Chronic Hepatitis B | Unknown status | NCT00597259 | Phase 4 | | 20 | Sustained Off-treatment Response After HBeAg Loss in Chronic Hepatitis B Patients Treated With Nucleos(t)Ide Analogues | Unknown status | NCT01911156 | Phase 4 | | 21 | Lamivudine Extending Therapy in Chronic Hepatitis B Patients After 3-year of Oral Antiviral Agents | Unknown status | NCT02337127 | Phase 4 | | 22 | Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and Delta | Unknown status | NCT00117533 | Phase 4 | | 23 | Efficacy and Safety of Entecavir Maleate Tablets in Chinese Patients With Hepatitis B | Unknown status | NCT01926288 | Phase 4 | | 24 | Efficacy Optimizing Research of Chronic Hepatitis B Patients With Inadequate Response to NUC Therapy | Unknown status | NCT01341743 | Phase 4 | | 25 | Using Entecavir to Reduce Hepatitis in Highly Viremic HBV Patients During Anti-tuberculous Treatment | Unknown status | NCT01724723 | Phase 4 | | 26 | Antiviral Therapy in Hepatitis B Virus (HBV)-Related Advanced Liver Disease Patients | Unknown status | NCT00823550 | Phase 4 | | 27 | Emtricitabine for Naive Child Chinese Chronic Hepatitis B Patients | Unknown status | NCT02327676 | Phase 4 | | 28 | A Randomized,Parallel-group Clinical Trial of Hepatitis B Vaccine With Different Dosages and Schedules in Healthy Adults | Unknown status | NCT02203357 | Phase 4 | | 29 | Efficacy and Safety of S-adenosyl-L-methionine in Treatment of Chronic Hepatitis B Patients With Cholestasis | Unknown status | NCT01998620 | Phase 4 | | 30 | Baracle Tab. ® Versus Baraclude Tab.® for Patients With HBeAg Chronic Hepatitis B | Unknown status | NCT01913431 | Phase 4 | | 31 | Comparison of Telbivudine Plus Adefovir With Lamivudine Plus Adefovir for the Treatment of Lamivudine-resistant Chronic Hepatitis B at 52 Weeks: A Pilot Study | Unknown status | NCT01804387 | Phase 4 | | 32 | Switch From Adefovir to Tenofovir in Chronic Hepatitis B for Suboptimal Response to Adefovir-based Combination Therapy | Unknown status | NCT01595633 | Phase 4 | | 33 | Efficacy of Telbivudine With or Without add-on Tenofovir According to Roadmap Strategy Compare With Entecavir | Unknown status | NCT01588912 | Phase 4 | | 34 | Effects of Short-term Atorvastatin Treatment on Vaccination Efficacy in Nonresponder Persons to Hepatitis B Vaccine | Unknown status | NCT01548326 | Phase 4 | | 35 | A Two-year Study of Telbivudine in HBeAg Negative Hepatitis | Unknown status | NCT01521975 | Phase 4 | | 36 | HBsAg Related Response Guided Therapy | Unknown status | NCT01456312 | Phase 4 | | 37 | Study of Effects and Safety Between Adefovir Dipivoxil Plus Polyene Phosphatidylcholine Versus Adefovir Dipivoxil Alone in Chronic Hepatitis B Patients | Unknown status | NCT01436539 | Phase 4 | | 38 | Safety and Efficacy of Telbivudine on Liver Cirrhosis in Patients With Chronic Hepatitis B (CHB) | Unknown status | NCT01380951 | Phase 4 | | 39 | Adolescents' Response to Hepatitis B Vaccine Booster Dose | Unknown status | NCT01341275 | Phase 4 | | 40 | Influence of Hepatic Steatosis on the Therapeutic Effect of Entecavir in Chronic Hepatitis B Patients | Unknown status | NCT01148576 | Phase 4 | | 41 | Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Positive Chronic Hepatitis B | Unknown status | NCT00921180 | Phase 4 | | 42 | Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Negative Chronic Hepatitis B | Unknown status | NCT00917761 | Phase 4 | | 43 | Prednisolone Priming Study in Patients With Chronic Hepatitis B | Unknown status | NCT00778596 | Phase 4 | | 44 | A Trial To Study The Effect Of Lamivudine In Adult Patients Who Suffer From Chronic Hepatitis B Alone | Unknown status | NCT00354653 | Phase 4 | | 45 | Efficacy of Antiviral Therapy After Radical Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma | Unknown status | NCT00768157 | Phase 4 | | 46 | Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using Transcatheter Arterial Chemoembolization (TACE) With Anti-hepatitis B Virus (Anti-HBV) Therapy | Unknown status | NCT01102335 | Phase 4 | | 47 | Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB | Completed | NCT01320943 | Phase 4 | | 48 | Immune Response of Healthy Subjects Who Received Neonatal Vaccination Course With Engerix™-B Vaccine. | Completed | NCT00774995 | Phase 4 | | 49 | Long-term Study With Clevudine | Completed | NCT00558818 | Phase 4 | | 50 | Evaluation of Chronic HBV Patients w/Evidence of HBV Replication and Normal or Minimally Elevated Liver Transaminases. | Completed | NCT00263614 | Phase 4 |
|
